SPIKEVAX XFG (50 Microgramm) Injektionsdispersion

7680708470027 CH-70847 J07BN01 08.08.

Active substances:

SARS-CoV-2 XFG mRNA

No images available

Details

Product number
7084701
CPT
-
Packaging group
10
Unit
Fertigspritze(n)
Composition
Suspension: SARS-CoV-2 XFG mRNA 50 µg pro dosi, heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas pro dosi, cholesterolum pro dosi, 1,2-distearoyl-sn-glycero-3-phosphocholinum pro dosi, 1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus pro dosi, trometamolum pro dosi, trometamoli hydrochloridum pro dosi, acidum aceticum pro dosi, natrii acetas trihydricus pro dosi, saccharum pro dosi, aqua ad iniectabile, pro dosi, natrium 0.017 mg pro dosi.

Articles (1)

Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze
Fertigspritze
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/08/2026
Patient information leaflet
Français
11/08/2026
Patient information leaflet
Italien
11/08/2026
Professional SmPC
Allemand
11/08/2026
Professional SmPC
Français
11/08/2026
Professional SmPC
Italien
11/08/2026

Detailed composition

Substance Quantity Type Category
SARS-CoV-2 XFG mRNA
50.0 UG Substance Wirkstoff (Principe actif)
heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas
- Substance HNIDK
cholesterolum
- Substance HNIDK
1,2-distearoyl-sn-glycero-3-phosphocholinum
- Substance HNIDK
1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus
- Substance HNIDK
trometamolum
- Substance HNIDK
trometamoli hydrochloridum
- Substance HNIDK
acidum aceticum
- Substance HNIDK
natrii acetas trihydricus
- Substance HNIDK
saccharum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.017 MG Substance HBESI

Reimbursement information

Public price
CHF 799.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2026

Authorization holder

Moderna Switzerland GmbH

4052 Basel

Authorization information

Swissmedic authorization number
70847
Drug name
Spikevax XFG
Galenic form
DISIJ
ATC Code
J07BN01
Authorization status
Z
Dispensation category
B
First authorization
10/08/2026
Authorization expiration date
09/08/2031
IT number
08.08.
Domain
Human medicine
Field of application
Spikevax XFG ist für die aktive Immunisierung zur Vorbeugung der durch das SARS-CoV-2-Virus verursachten Coronavirus-2019-Erkrankung (COVID-19) bei Personen ab 12 Jahren indiziert.

Packaging details

Description (FR)
SPIKEVAX XFG (50 Microgramm) Injektionsdispersion
Description (DE)
SPIKEVAX XFG (50 Microgramm) Injektionsdispersion
Market launch
01/09/2026
Narcotic (BTM)
No

Other packaging sizes

SPIKEVAX XFG (50 Microgramm) Injektionsdispersion
1 FESP
GTIN: 7680708470010
View
Buy us a coffee Explore the data